{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:04:38Z","timestamp":1790978678685,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.humpath.2007.06.021","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T16:03:15Z","timestamp":1200067395000},"page":"377-385","source":"Crossref","is-referenced-by-count":36,"title":["Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma"],"prefix":"10.1016","volume":"39","author":[{"given":"Anne H.","family":"V\u00e4is\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Kallioinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taina","family":"Turpeenniemi-Hujanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2007.06.021_bib1","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17600 melanoma patients: validation of the American joint committee on cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2007.06.021_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/07853890310009980","article-title":"New prognostic factors and developing therapy of cutaneous melanoma","volume":"35","author":"Vihinen","year":"2003","journal-title":"Ann Med"},{"key":"10.1016\/j.humpath.2007.06.021_bib3","first-page":"781","article-title":"Changing views of the role of matrix metalloproteinases in metastasis","volume":"13","author":"Chambers","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.humpath.2007.06.021_bib4","first-page":"135","article-title":"Matrix metalloproteinases: biologic activity and clinical implications","volume":"18","author":"Nelson","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2007.06.021_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biochi.2005.01.013","article-title":"Role of matrix metalloproteinases in melanoma cell invasion","volume":"87","author":"Hoffman","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.humpath.2007.06.021_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ijc.2910460224","article-title":"Modulation of type IV collagenase activity and invasive behaviour of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type IV collagenase","volume":"46","author":"H\u00f6yhty\u00e4","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib7","first-page":"4174","article-title":"The 92-kDa gelatinase B is expressed by advanced stage melanoma cells, suppression by somatic cell hybridization with early stage melanoma cells","volume":"55","author":"MacDougall","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2007.06.021_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/sj.bjc.6690417","article-title":"Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas","volume":"80","author":"Airola","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ijc.1636","article-title":"High expression of collagenase-1, and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma","volume":"97","author":"Nikkola","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<283::AID-PATH662>3.0.CO;2-3","article-title":"Matrix metalloproteinase-2 (72 kDa type IV collagenase) expression occurs in the early stage of human melanocytic tumor progression and may have prognostic value","volume":"80","author":"V\u00e4is\u00e4nen","year":"1996","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2007.06.021_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH632>3.0.CO;2-#","article-title":"Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type I matrix metalloproteinase (MT1-MMP) correlate with melanoma progression","volume":"191","author":"Hoffman","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2007.06.021_bib12","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/cncr.10888","article-title":"Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase-2 and matrix metalloproteinase-9 in cutaneous melanocytic lesions","volume":"95","author":"Simonetti","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<51::AID-PATH131>3.0.CO;2-P","article-title":"Prognostic value of MMP-2 immunoreactive protein (72 kDa type IV collagenase) in primary skin melanoma","volume":"186","author":"V\u00e4is\u00e4nen","year":"1998","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2007.06.021_bib14","first-page":"665","article-title":"Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment lesions of the skin","volume":"151","author":"Van den Oord","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2007.06.021_bib15","series-title":"Cutaneous melanoma","first-page":"213","article-title":"Classification and staging","author":"Ketcham","year":"2002"},{"key":"10.1016\/j.humpath.2007.06.021_bib16","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ijc.2910560408","article-title":"Immunohistochemical localization of matrix metalloproteinase-2 and its specific inhibitor TIMP-2 in neoplastic tissue with monoclonal antibodies","volume":"56","author":"H\u00f6yhty\u00e4","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib17","first-page":"1427","article-title":"Macrophages contain 92-kDa gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis","volume":"149","author":"Nikkari","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2007.06.021_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ijc.2910580422","article-title":"Modulation of Mr 72.000 and Mr 92.000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma","volume":"8","author":"Hujanen","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib19","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.bjc.6690385","article-title":"Proteolytic switching: opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression","volume":"80","author":"MacDougall","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s004320100257","article-title":"Serum matrix metalloproteinase-2 in patients with malignant melanoma","volume":"127","author":"Wollina","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2007.06.021_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2230.2005.01849.x","article-title":"Expression and serum levels of MMP-2 and MMP-9 during human progression","volume":"30","author":"Redondo","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.humpath.2007.06.021_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/028418600750063659","article-title":"Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma","volume":"39","author":"Vuoristo","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.humpath.2007.06.021_bib23","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/sj.bjc.6601238","article-title":"Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma","volume":"89","author":"Talvensaari-Mattila","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0090-4295(03)00660-5","article-title":"Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer","volume":"62","author":"Vasala","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2007.06.021_bib25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ygyno.2004.06.028","article-title":"Gelatinases A and B (MMP-2 and -9) in endometrial cancer\u2013MMP-9 correlates to the grade and stage","volume":"94","author":"Aglund","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2007.06.021_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biochi.2005.01.014","article-title":"Gelatinases (MMP-2 and MMP-9) and their natural inhibitors as prognostic indicators in solid cancers","volume":"87","author":"Turpeenniemi-Hujanen","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.humpath.2007.06.021_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1440-1827.1997.tb04525.x","article-title":"Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung","volume":"47","author":"Kodate","year":"1997","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2007.06.021_bib28","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1158\/1078-0432.CCR-03-0530","article-title":"Expression of MMP-9 in head and neck squamous cell cancer a potent marker for prognosis","volume":"11","author":"Ruokolainen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2007.06.021_bib29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1054\/bjoc.2001.1810","article-title":"Overexpression of matrix metalloproteinase-9 in human breast cancer: a potential favorable indicator in node-negative patients","volume":"84","author":"Scorilas","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2007.06.021_bib30","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1158\/1078-0432.CCR-04-2478","article-title":"High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma","volume":"11","author":"Nikkola","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2007.06.021_bib31","first-page":"4247","article-title":"Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy","volume":"24","author":"Rahko","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2007.06.021_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jsre.2001.6220","article-title":"Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity","volume":"102","author":"Pross","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.humpath.2007.06.021_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0960-0760(03)00386-8","article-title":"Activation of matrix metalloproteinase-1 and -9 by 2- and 4-hydroxyestradiol","volume":"87","author":"Paquette","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.humpath.2007.06.021_bib34","first-page":"253","article-title":"Apoptotic efficacy and inhibitory effect of dexamethasone on matrix metalloproteinases","volume":"11","author":"Saadat","year":"2005","journal-title":"Med Sci Monit"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707003826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817707003826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T20:35:37Z","timestamp":1557174937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817707003826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0046817707003826"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2007.06.021","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}